Quality problems more likely in offshore drug plants, study finds
Tuesday, September 6, 2011 - 13:00
in Health & Medicine
Drugs produced in offshore manufacturing plants -- even those run by U.S. manufacturers -- pose a greater quality risk than those prepared in the mainland United States, a new study suggests.
